William Blair reiterated their outperform rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research note issued to investors on Monday morning, RTT News reports. A number of other analysts have also issued reports on the company. Mizuho boosted their price target on Axsome Therapeutics from $84.00 to $95.00 in a report […]
Envestnet Asset Management Inc. reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.9% in the 1st quarter, HoldingsChannel.com reports. The fund owned 10,473 shares of the company’s stock after selling 1,548 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Axsome Therapeutics were worth $646,000 at the end […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price decreased by equities research analysts at HC Wainwright from $200.00 to $190.00 in a research report issued to clients and investors on Monday, FlyOnTheWall reports. HC Wainwright’s price objective indicates a potential upside of 156.17% from the stock’s current price. AXSM has been the […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report)’s share price rose 2.5% during mid-day trading on Thursday . The stock traded as high as $74.64 and last traded at $74.57. Approximately 480,521 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 926,140 shares. The stock had previously closed at […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been given an average recommendation of “Moderate Buy” by the thirteen ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and ten have assigned a buy recommendation to the […]